AnaptysBio Inc (ANAB)
20.10
-1.58
(-7.29%)
USD |
NASDAQ |
Nov 04, 13:09
AnaptysBio Price to Book Value: 55.85 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 60.24 |
| October 31, 2024 | 60.10 |
| October 30, 2024 | 61.63 |
| October 29, 2024 | 85.58 |
| October 28, 2024 | 84.72 |
| October 25, 2024 | 89.00 |
| October 24, 2024 | 89.52 |
| October 23, 2024 | 96.55 |
| October 22, 2024 | 97.67 |
| October 21, 2024 | 98.28 |
| October 18, 2024 | 97.19 |
| October 17, 2024 | 97.75 |
| October 16, 2024 | 96.39 |
| October 15, 2024 | 92.44 |
| October 14, 2024 | 96.53 |
| October 11, 2024 | 92.30 |
| October 10, 2024 | 88.91 |
| October 09, 2024 | 87.33 |
| October 08, 2024 | 89.89 |
| October 07, 2024 | 91.69 |
| October 04, 2024 | 94.42 |
| October 03, 2024 | 97.33 |
| October 02, 2024 | 97.25 |
| October 01, 2024 | 96.72 |
| September 30, 2024 | 93.08 |
| Date | Value |
|---|---|
| September 27, 2024 | 88.55 |
| September 26, 2024 | 90.33 |
| September 25, 2024 | 89.86 |
| September 24, 2024 | 96.92 |
| September 23, 2024 | 98.83 |
| September 20, 2024 | 106.92 |
| September 19, 2024 | 104.28 |
| September 18, 2024 | 101.61 |
| September 17, 2024 | 104.20 |
| September 16, 2024 | 107.59 |
| September 13, 2024 | 112.06 |
| September 12, 2024 | 106.42 |
| September 11, 2024 | 98.93 |
| September 10, 2024 | 97.64 |
| September 09, 2024 | 98.85 |
| September 06, 2024 | 99.75 |
| September 05, 2024 | 102.22 |
| September 04, 2024 | 103.17 |
| September 03, 2024 | 100.25 |
| August 30, 2024 | 105.84 |
| August 29, 2024 | 101.75 |
| August 28, 2024 | 102.17 |
| August 27, 2024 | 102.36 |
| August 26, 2024 | 103.70 |
| August 23, 2024 | 104.89 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6563
Minimum
Nov 08 2019
112.06
Maximum
Sep 13 2024
9.359
Average
2.276
Median
Mar 10 2022
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 3.141 |
| Ligand Pharmaceuticals Inc | 2.587 |
| Agios Pharmaceuticals Inc | 3.851 |
| ADMA Biologics Inc | 23.84 |
| Black Diamond Therapeutics Inc | 1.532 |
Price to Book Value Related Metrics
| PS Ratio | 17.69 |
| PEG Ratio | -0.1417 |
| Price | 20.10 |
| Earnings Yield | -31.59% |
| Market Cap | 551.73M |
| PEGY Ratio | -0.1417 |